Edgewise Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
EWTX
CUSIP
28036F105
Type
Equity
Class
COM
Num filings
215
Total reported value, excl. options
$3.02 B
Manager Report Date Value ($000) Shares Option Type